Núria Amigó

TL;DR: The Liposcale test, a novel ALT based on 2D diffusion-ordered 1H NMR spectroscopy, provides reproducible and reliable characterization of lipoprotein particles and it is applicable to pathological states such as AD.

TL;DR: The applications reviewed here demonstrated that GlycA was potentially a key biomarker in a wide range of diseases such as cancer, metabolic diseases, cardiovascular risk, and chronic inflammatory diseases among others and launches an encouraging new paradigm for its future incorporation in clinical diagnosis.

TL;DR: LD particles showed the strongest association with cardiovascular events when the particle composition, rather than the total concentration, was investigated, and a change in baseline composition of LDL particles from large to medium and small LDL particles was associated with an increased cardiovascular risk, especially for CHD.

TL;DR: Plasma HDL-TG concentrations were higher as metabolic syndrome components increased and was also higher with worsening glucose metabolism, and patients with carotid plaques also showed higher HDL- TG.

TL;DR: PCSK9 plasma levels are increased in patients with type 2 diabetes and MetS patients and are associated with LDL-C and other parameters of AD and glucose metabolism.